Prosecution Insights
Last updated: May 29, 2026

Nutrition & Biosciences USA 4, Inc.

6 pending office actions • 4 art units • 5 examiners • 0 of 6 (0%) have an AI response strategy ready • 7 patents granted in the last 365 days

Portfolio Summary

6
Total Pending OAs
6
Non-Final OAs
0
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 6 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

3
Overdue
0
Due this week
1
Due this month
0
Due in next 60 days
2
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 6 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (3)Due ≤ 30 days (1)Due later (2)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
5
Medium (83%)
0
Easy (0%)
1
Unknown (17%)

Rejection Statute Mix

BucketCases
§103 only5 (83%)
No statute on record1 (17%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

6
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

60 h
Manual time on pending OAs
12 h
Time saved (low, 20%)
21 h
Time saved (mid, 35%)
0.5 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
DELCOTTO, GREGORY R 2 53.8% +75.7%
MRUK, BRIAN P 1 74.2% +27.5%
SILVERMAN, JANICE Y 1 36.2% +52.8%
GREENE, IVAN A 1 18.7% +6.6%
MCINTOSH III, TRAVISS C 1 73.3% +13.9%

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18576406 CATIONIC GLUCAN ESTER DERIVATIVES GREENE, IVAN A 70d

Interview Candidates (5)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.

App #TitleExaminerDue in
18546466 POLYSACCHARIDE DERIVATIVES FOR DETERGENT COMPOSITIONS DELCOTTO, GREGORY R 24d overdue
18546457 OXIDIZED POLYSACCHARIDE DERIVATIVES DELCOTTO, GREGORY R 24d overdue
18621556 GLUCAN FIBER COMPOSITIONS FOR USE IN LAUNDRY CARE AND FABRIC CARE MRUK, BRIAN P 9d overdue
18495216 NONWOVEN GLUCAN WEBS MCINTOSH III, TRAVISS C 14d
18695603 OPTIMIZED WATER LINE DELIVERY OF MICROBES SILVERMAN, JANICE Y 70d

Top Art Units

Art UnitApps
1761 3
1792 1
1619 1
1693 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18621556 GLUCAN FIBER COMPOSITIONS FOR USE IN LAUNDRY CARE AND FABRIC CARE MRUK, BRIAN P 1761 Other Non-Final OA 9d overdue Pending Mar 29, 2024
18695603 OPTIMIZED WATER LINE DELIVERY OF MICROBES SILVERMAN, JANICE Y 1792 §103 Non-Final OA 70d Pending Mar 26, 2024
18576406 CATIONIC GLUCAN ESTER DERIVATIVES GREENE, IVAN A 1619 §103 Non-Final OA 70d Pending Jan 04, 2024
18495216 NONWOVEN GLUCAN WEBS MCINTOSH III, TRAVISS C 1693 §103 Non-Final OA 14d Pending Oct 26, 2023
18546466 POLYSACCHARIDE DERIVATIVES FOR DETERGENT COMPOSITIONS DELCOTTO, GREGORY R 1761 §103 Non-Final OA 24d overdue Pending Aug 15, 2023
18546457 OXIDIZED POLYSACCHARIDE DERIVATIVES DELCOTTO, GREGORY R 1761 §103 Non-Final OA 24d overdue Pending Aug 15, 2023

Managing Nutrition & Biosciences USA 4, Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month